I am a medical oncologist who is dedicated to improving the lives of people with genitourinary cancer. My primary area of expertise is kidney cancer (renal cell carcinoma). In particular, I care for people who have cancer that has spread to other parts of the body or who are at high risk for cancer spreading.

For more than 30 years, I have provided high-quality and compassionate care for MSK patients with kidney cancer and other advanced genitourinary cancers. As Kidney Cancer Section Head, I lead a group of experts who are dedicated to researching and treating this disease.

I have led more than 80 clinical trials in people with kidney cancer and testicular cancer. These have included national and international multicenter clinical trials. My research has helped identify ten groundbreaking targeted drugs that are effective treatments for people with advanced kidney cancer.

On both a national and international level, I work to improve the quality and delivery of care for people with kidney cancer. I developed a risk-based system to help predict treatment outcomes for people taking medications for advanced kidney cancer. This system is used by doctors around the world to guide patient care. I also chair the Kidney Cancer Guidelines Panel for the National Comprehensive Cancer Network.

I have published more than 500 scientific articles, reviews, and chapters. I have given lectures throughout the world, from Japan and China, to Russia and Turkey, to Germany, Spain, and Brazil. I am a recipient of a Career Development Award from the National Institutes of Health, the Willet F. Whitmore Award for Clinical Excellence from Memorial Sloan Kettering, and the Eugene P. Schonfeld Award from the Kidney Cancer Association.